Xenon Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update

Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 9c

August 10, 2015 5:10 PM EDT

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.07), $0.09 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

... More